Clinical trial
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry
NCT03118037 · Gynesonics, Industry · Terminated
Key facts
| NCT number | NCT03118037 |
|---|---|
| Title | Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry |
| Official title | Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE) |
| Acronym | SAGE |
| Lead sponsor | Gynesonics, Industry |
| Status | Terminated |
| Study type | Observational [Patient Registry] |
| Conditions | Uterine Fibroid |
| Intervention type | Device |
| Interventions | Sonata System |
| Enrollment | 182 |
| Start date | Jun 14, 2017 |
| Primary completion | Nov 11, 2024 |
| Completion | Nov 11, 2024 |
| First posted | Apr 18, 2017 |
| Last update posted | Dec 16, 2024 |
| Countries | Germany, Switzerland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: